drugset / Trial / NCT01273974
The Immunogenicity of Intradermal Influenza Vaccination in Hemodialysis Patients
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to determine whether half-dose intradermal influenza vaccine is as immunogenic as standard dose intramuscular vaccine in hemodialysis patients.
Timeline
- Start
- 2009-10
- Primary completion
- 2009-11
- Completion
- 2010-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Influenza Virus Vaccine | Vaccine | 0.25 ml | Intramuscular |
| Comparator | Influenza Virus Vaccine | Vaccine | 0.5 ml | Intramuscular |
Indications
No indication recorded.